Sophia Kenrick serves as the Director of Analytical Sciences at Wyatt Technology, where she plays a pivotal role in advancing the company’s capabilities in biophysical characterization and macromolecular analysis. With a strong foundation in biochemistry and a meticulous approach to problem-solving, Sophia synthesizes data from...
Sophia Kenrick serves as the Director of Analytical Sciences at Wyatt Technology, where she plays a pivotal role in advancing the company’s capabilities in biophysical characterization and macromolecular analysis. With a strong foundation in biochemistry and a meticulous approach to problem-solving, Sophia synthesizes data from a diverse array of biochemical and biophysical techniques to unravel the complexities of biomacromolecule behavior. Her expertise spans critical methodologies such as multi-angle light scattering (MALS), dynamic light scattering (DLS), surface plasmon resonance (SPR), and fluorescence resonance energy transfer (FRET), enabling her to investigate macromolecular interactions with precision.
In her current role, Sophia directs and supervises in-house sample analyses while also leading onsite demonstrations and seminars tailored for sales and marketing teams. Her ability to communicate complex scientific concepts effectively has been instrumental in bridging the gap between technical insights and commercial applications. Sophia is also deeply involved in supporting product development initiatives, focusing on creating innovative applications for existing products that meet the evolving needs of the industry.
Key projects under her leadership include the development of advanced analytical techniques that enhance the characterization of protein interactions and stability, which are crucial for therapeutic development. Her hands-on experience with protein purification, gel electrophoresis, and chromatography further solidifies her reputation as a leader in the field. As a team leader, Sophia fosters a collaborative environment that encourages knowledge sharing and innovation, ensuring that Wyatt Technology remains at the forefront of analytical solutions in the biopharmaceutical sector.
